Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by rythmanon Jun 21, 2007 2:57pm
623 Views
Post# 12979791

Reseveratrol...

Reseveratrol...is a compound found largely in the skins of red grapes and is a phytalexin produced by several plants that is sold as a nutritional supplement and is readily available at your natural paths office. They use it as a anti cancer agent. Plants produce the phytoalexin as a defense against fungal growth as a protective buffer. Esperion is a company that was bought by Pfizer because they working with a treatment ustilizing these phytalexins as a artery cleaning agent offered through a IV solution. Hence the inclusion of thier founder on Reverlogix board. The problem with this treatment is that is both expensive and time consuming. Hence Resverlogix, if they can produce the same increase in HDL through a less combersome approach then Pfizer has to be interested. Esperion was bought by Pfizer in 2004 for I think 1.3 Billion. Hence the need for someone to do the necessary clinical trials. cheers rythman
Bullboard Posts